AVANOS MEDICAL, INC.
AVNSUS売上高
$701M
百万USD
営業利益
$-62M
百万USD
純利益
$-73M
百万USD
ROE
-9.4%
最新FY
EPS
$-1.57
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $181M | $-8M | $-0.16 |
| FY2021 | Q2 | $186M | $38M | $0.78 |
| FY2021 | Q3 | $184M | $-35M | $-0.73 |
| FY2021 | FY | $745M | $5M | $0.11 |
| FY2022 | Q1 | $197M | $6M | $0.12 |
| FY2022 | Q2 | $203M | $11M | $0.24 |
| FY2022 | Q3 | $202M | $16M | $0.33 |
| FY2022 | FY | $820M | $51M | $1.07 |
| FY2023 | Q1 | $192M | $-0M | $-0.01 |
| FY2023 | Q2 | $169M | $-68M | $-1.46 |
| FY2023 | Q3 | $171M | $-4M | $-0.08 |
| FY2023 | FY | $673M | $-62M | $-1.32 |
| FY2024 | Q1 | $166M | $-1M | $-0.02 |
| FY2024 | Q2 | $172M | $2M | $0.04 |
| FY2024 | Q3 | $170M | $4M | $0.09 |
| FY2024 | FY | $688M | $-392M | $-8.53 |
| FY2025 | Q1 | $168M | $7M | $0.14 |
| FY2025 | Q2 | $175M | $-77M | $-1.66 |
| FY2025 | Q3 | $178M | $-1M | $-0.03 |
| FY2025 | FY | $701M | $-73M | $-1.57 |
| FY2026 | Q1 | $182M | $5M | $0.11 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $652M | $698M | $715M | $745M | $820M | $673M | $688M | $701M |
| 営業利益 | $87M | $-43M | $1M | $-56M | $-46M | $9M | $74M | $4M | $-396M | $-62M |
| 純利益 | $40M | $79M | $58M | $-46M | $-27M | $5M | $51M | $-62M | $-392M | $-73M |
| 総資産 | $2.1B | $2.2B | $1.8B | $1.8B | $1.7B | $1.6B | $1.8B | $1.7B | $1.2B | $1.1B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $1.1B | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $829M | $778M |
| 営業CF | $189M | $144M | $-146M | $-74M | $-2M | $87M | $91M | $32M | $101M | $75M |
| EPS | $0.85 | $1.69 | $1.22 | $-0.96 | $-0.57 | $0.11 | $1.07 | $-1.32 | $-8.53 | $-1.57 |
| BPS | $23.62 | $25.90 | $27.34 | $26.49 | $26.20 | $26.71 | $27.71 | $26.76 | $18.01 | $16.73 |
| ROE | 3.6% | 6.5% | 4.4% | -3.6% | -2.2% | 0.4% | 3.9% | -5.0% | -47.3% | -9.4% |